XML 43 R30.htm IDEA: XBRL DOCUMENT
v3.24.0.1

INVESTMENTS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Investments, All Other Investments [Abstract] |
Schedule of Cash and Financial Assets Measured at Fair Value on a Recurring Basis | The following tables present the Company’s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):
| December 31, 2023
| Cost |  | Unrealized Gains |  | Accrued Interest |  | Estimated Fair Value |  | Cash & Cash Equivalents |  | Investment Securities
Cash and cash equivalents, excluding money market accounts | $ | 88,778 |  |  | $ | — |  |  | $ | — |  |  | $ | 88,778 |  |  | $ | 88,778 |  |  | $ | — |
Level 1: |  |  |  |  |  |  |  |  |  |  |
Money market accounts | 5,662 |  |  | — |  |  | — |  |  | 5,662 |  |  | 5,662 |  |  | — |
Government & agency securities | 15,282 |  |  | 126 |  |  | 40 |  |  | 15,448 |  |  | — |  |  | 15,448 |
Equity securities | 10,000 |  |  | 150 |  |  | — |  |  | 10,150 |  |  | — |  |  | 10,150 |
| 30,944 |  |  | 276 |  |  | 40 |  |  | 31,260 |  |  | 5,662 |  |  | 25,598 |
Level 2: |  |  |  |  |  |  |  |  |  |  |
Corporate bonds | 29,440 |  |  | 293 |  |  | 270 |  |  | 30,003 |  |  | — |  |  | 30,003 |
Total | $ | 149,162 |  |  | $ | 569 |  |  | $ | 310 |  |  | $ | 150,041 |  |  | $ | 94,440 |  |  | $ | 55,601 |
| December 31, 2022
| Cost |  | Unrealized Gains |  | Accrued Interest |  | Estimated Fair Value |  | Cash & Cash Equivalents |  | Investment Securities
Cash and cash equivalents | $ | 87,691 |  |  | $ | — |  |  | $ | — |  |  | $ | 87,691 |  |  | $ | 87,691 |  |  | $ | — |
Total | $ | 87,691 |  |  | $ | — |  |  | $ | — |  |  | $ | 87,691 |  |  | $ | 87,691 |  |  | $ | — |
Summary of Investment Gains | The gains related to the Company's LifeMD investment for the year ended December 31, 2023, 2022 and 2021 are summarized in the table below (in thousands):
| December 31, 2023 |  | December 31, 2022 |  | December 31, 2021
Net gains recognized during the period on equity securities | $ | 150 |  |  | $ | — |  |  | $ | — |
Less: Net gains recognized on equity securities sold | — |  |  | — |  |  | — |
Unrealized gains recognized during the reporting period on equity securities still held at the reporting date | $ | 150 |  |  | $ | — |  |  | $ | — |

X
- Definition Tabular disclosure of realized and unrealized gain (loss) on investment in security. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(7)(c)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(9)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_GainLossOnInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration